Pharma

Catalent flags problems at its manufacturing plants; CFO departs

April 14, 2023 10:50 PM AEST | By Reuters

(Reuters) - Contract drug manufacturer Catalent Inc on Friday warned that low production at three of its facilities and higher costs would impact its...

Contract drug manufacturer Catalent warns of hit to fourth-quarter r...

April 14, 2023 09:43 PM AEST | By Reuters

(Reuters) -Contract drug manufacturer Catalent Inc on Friday warned that its fiscal fourth-quarter results would be hit by lower productivity and high...

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight

April 12, 2023 03:00 AM AEST | By Reuters

By Blake Brittain (Reuters) - A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp paten...

Bayer's pharma chief hopes EU takes time to improve drug rules refor...

March 25, 2023 03:26 AM AEDT | By Reuters

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - The European Union's decision to postpone rule changes for the pharmaceutical industry could...

J&J to seek U.S. Supreme Court review on unit's bankruptcy

March 23, 2023 02:24 AM AEDT | By Reuters

(Reuters) - Johnson & Johnson said on Wednesday that it would seek a U.S. Supreme Court review of its strategy to address tens of thousands of law...

Novartis launches new share buyback for up to 10% of its stock

March 13, 2023 05:19 PM AEDT | By Reuters

ZURICH (Reuters) - Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company's own shares over the next three ye...

Britain's NICE to speed up reviews of COVID-19 treatments

February 16, 2023 11:39 AM AEDT | By Reuters

(Corrects to remove erroneous word in headline) By Maggie Fick LONDON (Reuters) - Britain's agency that determines if medicines should be used in the...

U.S. government to buy 1.5 million more Novavax COVID vaccine doses

February 14, 2023 02:32 AM AEDT | By Reuters

(Reuters) - The U.S. government has agreed to buy 1.5 million more doses of Novavax Inc COVID-19 vaccine, the company said on Monday, adding that the...

Kidney dialysis-related infection rates higher in U.S. minorities -r...

February 07, 2023 07:15 AM AEDT | By Reuters

By Nancy Lapid (Reuters) - Preventable bloodstream infections related to kidney failure treatment are more common in U.S. Blacks and Hispanics than in...

U.S. FDA says India-made eye drop linked to some infections, blindne...

February 04, 2023 02:43 AM AEDT | By Reuters

NEW DELHI (Reuters) - The U.S. Food and Drug Administration has warned against using an India-made eye drop that has been linked to the outbreak of a...

Regeneron quarterly profit plunges as COVID drug sales dry up

February 03, 2023 10:51 PM AEDT | By Reuters

(Reuters) - Regeneron Pharmaceuticals Inc reported an about 46% plunge in its fourth-quarter profit on Friday, hurt by a drop in U.S. sales of its blo...

Regeneron quarterly profit drops 46%

February 03, 2023 10:37 PM AEDT | By Reuters

(Reuters) - Regeneron Pharmaceuticals Inc reported an about 46% plunge in its fourth-quarter profit on Friday, hurt by a drop in U.S. sales of its blo...

Mailing abortion pills could break law, Republican AGs tell pharmaci...

February 03, 2023 04:10 AM AEDT | By Reuters

By Brendan Pierson (Reuters) - A group of 20 Republican state attorneys general on Wednesday told Walgreens Boots Alliance Inc and CVS Health Corp tha...

Merck sees sharp decline in COVID sales for 2023 after strong fourth...

February 03, 2023 02:08 AM AEDT | By Reuters

By Michael Erman (Reuters) - Merck & Co on Thursday forecast 2023 earnings below Wall Street estimates along with an expected steep decline in sal...

Pfizer forecasts 2023 sales of COVID products below estimates

January 31, 2023 10:48 PM AEDT | By Reuters

(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products that fell short of Wall Street expectations, hit by lower demand in int...

U.S. CDC still looking at potential stroke risk from Pfizer bivalent...

January 27, 2023 05:31 AM AEDT | By Reuters

By Michael Erman (Reuters) - New data from one U.S. Centers for Disease Control and Prevention (CDC) database shows a possible stroke risk link for ol...

J&J quarterly profit beats on pharmaceuticals strength

January 24, 2023 10:33 PM AEDT | By Reuters

(Reuters) -Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates as it bets on stronger demand for its pharmaceuticals p...

U.S. asks judge to hold Shkreli in contempt for flouting pharma indu...

January 21, 2023 04:49 AM AEDT | By Reuters

WASHINGTON (Reuters) - The U.S. Federal Trade Commission asked a federal judge on Friday to hold Martin Shkreli in contempt for allegedly flouting a j...

Senegal institute wins $50 million in boost to Africa's vaccine capa...

January 20, 2023 12:54 AM AEDT | By Reuters

By Natalie Grover and Nellie Peyton JOHANNESBURG (Reuters) - The Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 year...

Indonesia court hears class-action suit after children die from tain...

January 17, 2023 07:33 PM AEDT | By Reuters

JAKARTA (Reuters) - Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday sta...

Companies

Education